We are live on ! Find out more
INSM icon

Insmed

415 hedge funds and large institutions have $13.7B invested in Insmed in 2024 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 184 increasing their positions, 115 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more first-time investments, than exits

New positions opened: 74 | Existing positions closed: 38

82% more capital inflows, than outflows

Capital inflows: $2.18B | Capital outflows: $1.2B

60% more repeat investments, than reductions

Existing positions increased: 184 | Existing positions reduced: 115

10% more funds holding

Funds holding: 378 → 415 (+37)

0.7% more ownership

Funds ownership: 108.69% → 109.39% (+0.7%)

0% more funds holding in top 10

Funds holding in top 10: 27 → 27 (0)

35% less call options, than puts

Call options by funds: $173M | Put options by funds: $268M

Holders
415
Holders Change
+37
Holders Change %
+9.79%
% of All Funds
5.94%
Holding in Top 10
27
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.39%
New
74
Increased
184
Reduced
115
Closed
38
Calls
$173​M
Puts
$268​M
Net Calls
-⁠$94.8​M
Net Calls Change
-⁠$83.9​M

INSM Hedge Fund Activity: Q3 2024 in Review

415 of the 6,990 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q3 2024, worth a combined $13.7B — up 17% from $11.7B a quarter earlier.

Buyers outnumbered sellers: 74 funds opened new INSM positions and 38 closed out — a net gain of 36 holders — while 184 added to existing stakes and 115 trimmed.

The largest buyer was Darwin Global Management, adding an estimated $513M. The largest seller was Deep Track Capital, exiting entirely with an estimated $134M sold.

  • 415 institutional investors held Insmed (INSM) as of Q3 2024, up from 378 in Q2 2024.
  • Funds reported $13.7B of Insmed stock for Q3 2024, up 17% quarter-over-quarter.
  • 74 funds opened new Insmed positions in Q3 2024 and 38 closed out, a net change of +36 holders.
  • The largest Insmed buyer in Q3 2024 was Darwin Global Management, an estimated $513M added.
  • The largest Insmed seller in Q3 2024 was Deep Track Capital, an estimated $134M sold.

Based on aggregated 13F filings for Q3 2024.